Research in preclinical models suggests that AOD 9604 may support lipolysis by upregulating beta-3 adrenergic receptor expression and inhibiting new fat cell formation, with human trial data confirming no IGF-1 elevation or glucose disruption [2, 3]
Without a healthcare provider to guide the process, people often take incorrect doses or skip the necessary gradual titration, which can result in severe gastrointestinal issues and, in some cases, hospitalizations
Orally administrated diabetic (intraperitoneal injection of streptozotocin 60 mg/kg) and control Wistar rats were supplemented with vitamin E (0.2, 0.4, 0.8 mg/kg for 3 weeks)
And that comes from a well-planned GLP-1 supportive diet
PubMed DOI Lintner K, Peschard O
Targeting NPs to central appetite control centers may significantly enhance anti-obesity efficacy through localized delivery and synergistic action